African American Youth and Parent Perspectives on Advanced Insulin Delivery Technologies in Diabetes Management: Challenges to Closing the Loop on Health Disparities
Restricted accessResearch articleFirst published online February, 2026
African American Youth and Parent Perspectives on Advanced Insulin Delivery Technologies in Diabetes Management: Challenges to Closing the Loop on Health Disparities
The purpose of the study was to understand challenges to optimal diabetes management for African American (AA) youth and willingness to use advanced diabetes technologies.
Methods
Twenty AA youth with type 1 diabetes mellitus (mean age 13.81 ± 2.10 years; 8 girls and 12 boys) and their parents participated in focus groups or individual interviews addressing adherence barriers and attitudes about new technologies, such as the advanced hybrid closed loop (AHCL) insulin pump. Sessions were video recorded, and based on verbatim transcripts, 2 independent raters coded responses into themes, and a third rater resolved discrepancies; thematic analysis was conducted using NVivo.
Results
Qualitative analyses revealed 6 main themes encompassing current regimens, life with diabetes, parenting, culture, willingness to try new technologies, and hesitancy to try an AHCL system. Most families (65%) reported being very willing to try the AHCL system, and a third were open but not ready to commit, citing concerns about reliance on technology and need for more information.
Conclusions
Innovative technology, such as the AHCL insulin pump system, may help to improve glycemic outcomes and reduce health disparities for AA youth. Many AA youth with type 1 diabetes mellitus and their parents are ready to try advanced technologies but may require additional individualized support from the health care team to achieve optimal outcomes.
Get full access to this article
View all access options for this article.
References
1.
CengizEChengPRuedyKJ, et al. Clinical outcomes in youth beyond the first year of type 1 diabetes: results of the Pediatric Diabetes Consortium (PDC) Type 1 diabetes new onset (NeOn) study. Pediatr Diabetes. 2017;18(7):566-573. doi:10.1111/pedi.12459
2.
The DCCT Research Group. Diabetes Control and Complications Trial (DCCT): results of feasibility study. Diabetes Care. 1987;10(1):1-19. doi:10.2337/diacare.10.1.1
3.
Diabetes Control and Complications Trial (DCCT)/Epidemiology of Diabetes Interventions and Complications (EDIC) Study Research Group. Mortality in type 1 diabetes in the DCCT/EDIC versus the general population. Diabetes Care. 2016;39(8):1378-1383. doi:10.2337/dc15-2399
4.
The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in IDDM. N Engl J Med. 1993;329:977-983. doi:10.1056/NEJM199309303291401
5.
NathanDM.Realising the long-term promise of insulin therapy: the DCCT/EDIC study. Diabetologia. 2021;64(5):1049-1058. doi:10.1007/s00125-021-05397-4
6.
WhiteNHSunWClearyPA, et al. Effect of prior intensive therapy in type 1 diabetes on 10-year progression of retinopathy in the DCCT/EDIC: comparison of adults and adolescents. Diabetes. 2010;59(5):1244-1253. doi:10.2337/db09-1216
7.
Pop-BusuiRHermanWHFeldmanEL, et al. DCCT and EDIC studies in type 1 diabetes: lessons for diabetic neuropathy regarding metabolic memory and natural history. Curr Diab Rep. 2010;10(4):276-782. doi:10.1007/s11892-010-0120-8
8.
LachinJMNathanDM.Understanding metabolic memory: the prolonged influence of glycemia during the Diabetes Control and Complications Trial (DCCT) on future risks of complications during the Study of the Epidemiology of Diabetes Interventions and Complications (EDIC). Diabetes Care. 2021;44(10):2216-2224. doi:10.2337/dc20-3097
9.
FairchildJMHingSJDonaghueKC, et al. Prevalence and risk factors for retinopathy in adolescents with type 1 diabetes. Med J Aust. 1994;160(12):757-762. doi:10.5694/j.1326-5377.1994.tb125943.x
10.
DonaghueKCFairchildJMCraigME, et al. Do all prepubertal years of diabetes duration contribute equally to diabetes complications?Diabetes Care. 2003;26(4):1224-1229. doi:10.2337/diacare.26.4.1224
11.
DiMeglioLAAceriniCLCodnerE, et al. ISPAD clinical practice consensus guidelines 2018: glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes. Pediatr Diabetes. 2018;19(suppl 27):105-114. doi:10.1111/pedi.12737
12.
American Diabetes Association. 13. Children and adolescents: standards of medical care in diabetes-2021. Diabetes Care. 2021;44(suppl 1):S180-S199. doi:10.2337/dc21-S013
13.
RedondoMJLibmanIMaahsDM, et al. The evolution of hemoglobin A(1c) targets for youth with type 1 diabetes: rationale and supporting evidence. Diabetes Care. 2021;44(2):301-312. doi:10.2337/dc20-1978
14.
DelamaterAMAlbrechtDRPostellonDCGutaiJP.Racial differences in metabolic control of children and adolescents with type 1 diabetes mellitus. Diabetes Care. 1991;14(1):20-25. doi:10.2337/diacare.14.1.20
15.
DelamaterAMShawKHApplegateEB, et al. Risk for metabolic control problems in minority youth with diabetes. Diabetes Care. 1999;22(5):700-705. doi:10.2337/diacare.22.5.700
16.
ChalewSAGomezRButlerA, et al. Predictors of glycemic control in children with type 1 diabetes: the importance of race. J Diabetes Complications. 2000;14(2):71-77. doi:10.1016/S1056-8727(00)00072-6
17.
PetittiDBKlingensmithGJBellRA, et al. Glycemic control in youth with diabetes: the SEARCH for diabetes in Youth Study. J Pediatr. 2009;155(5):668-672.e3. doi:10.1016/j.jpeds.2009.05.025
18.
KampsJLHempeJMChalewSA.Racial disparity in hemoglobin A1c independent of mean blood glucose in children with type 1 diabetes. Diabetes Care. 2010;33:1025-1027. doi:10.2337/dc09-1440
19.
RedondoMJConnorCGRuedyKJ, et al. Pediatric diabetes consortium type 1 diabetes new onset (NeOn) study: factors associated with HbA1c levels one year after diagnosis. Pediatr Diabetes. 2014;15(4):294-302. doi:10.1111/pedi.12061
20.
WilliSMMillerKMDiMeglioLA, et al. Racial-ethnic disparities in management and outcomes among children with type 1 diabetes. Pediatrics. 2015;135(3):424-434. doi:10.1542/peds.2014-1774
21.
LadoJJLipmanTH.Racial and ethnic disparities in the incidence, treatment, and outcomes of youth with type 1 diabetes. Endocrinol Metab Clin North Am. 2016;45(2):453-461. doi:10.1016/j.ecl.2016.01.002
22.
RedondoMJLibmanIChengP, et al. Racial/ethnic minority youth with recent-onset type 1 diabetes have poor prognostic factors. Diabetes Care. 2018;41(5):1017-1024. doi:10.2337/dc17-2335
23.
KahkoskaARShayCMCrandellJ, et al. Association of race and ethnicity with glycemic control and hemoglobin A1c levels in youth with type 1 diabetes. JAMA Netw Open. 2018;1(5):e181851. doi:10.1001/jamanetworkopen.2018.1851
24.
TullESBarinasE.A twofold excess mortality among Black compared with White IDDM patients in Allegheny County, Pennsylvania. Pittsburgh DERI Mortality Study Group. Diabetes Care. 1996;19(12):1344-1347. doi:10.2337/diacare.19.12.1344
25.
NathanDMZinmanBClearyPA, et al. Modern-day clinical course of type 1 diabetes mellitus after 30 years’ duration: the diabetes control and complications trial/epidemiology of diabetes interventions and complications and Pittsburgh epidemiology of diabetes complications experience (1983-2005). Arch Intern Med. 2009;169(14):1307-1316. doi:10.1001/archinternmed.2009.193
26.
SecrestAMBeckerDJKelseySFLaporteREOrchardTJ.Cause-specific mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes. Diabetes. 2010;59(12):3216-3222. doi:10.2337/db10-0862
27.
SecrestAMBeckerDJKelseySFLaPorteREOrchardTJ.All-cause mortality trends in a large population-based cohort with long-standing childhood-onset type 1 diabetes: the Allegheny County Type 1 diabetes registry. Diabetes Care. 2010;33(12):2573-2579. doi:10.2337/dc10-1170
28.
ConwayBNLopes-VirellaMFBlotWJ.Late adulthood mortality among African-American and White American people with type 1 diabetes according to age at diabetes diagnosis. Diabet Med. 2018;35(6):729-736. doi:10.1111/dme.13617
29.
ParisCAImperatoreGKlingensmithG, et al. Predictors of insulin regimens and impact on outcomes in youth with type 1 diabetes: the SEARCH for Diabetes in Youth study. J Pediatrics. 2009;155(2):183-189. doi:10.1016/j.jpeds.2009.01.063
30.
LinMHConnorCGRuedyKJ, et al. Race, socioeconomic status, and treatment center are associated with insulin pump therapy in youth in the first year following diagnosis of type 1 diabetes. Diabetes Technol Ther. 2013;15(11):929-934. doi:10.1089/dia.2013.0132
31.
LipmanTHPatilOWilliSMHawkesCP.Racial disparities in treatment and outcomes of children with type 1 diabetes. Pediatric Diabetes. 2020;22:241-248. doi:10.1111/pedi.13139
32.
AuslanderWFThompsonSDreitzerDWhiteNHSantiagoJV.Disparity in glycemic control and adherence between African American and Caucasian youths with diabetes. Family and community contexts. Diabetes Care. 1997;20(10):1569-1575. doi:10.2337/diacare.20.10.1569
33.
MillerKMBeckRWBergenstalRM, et al. Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants. Diabetes Care. 2013;36(7):2009-2014. doi:10.2337/dc12-1770
34.
ChalewSGomezRVargasA, et al. Hemoglobin A1c, frequency of glucose testing and social disadvantage: metrics of racial health disparity in youth with type 1 diabetes. J Diabetes Complications. 2018;32(12):1085-1090. doi:10.1016/j.jdiacomp.2018.02.008
35.
ChalewSAHarrisonJBerryS.Achievement of glycemic outcome goals in pediatric diabetes: the impact of staff number. J La State Med Soc. 2008;160(6):328-332.
36.
ValenzuelaJMSeidMWaitzfelderB, et al. Prevalence of and disparities in barriers to care experienced by youth with type 1 diabetes. J Pediatr. 2014;164(6):1369-1375.e1. doi:10.1016/j.jpeds.2014.01.035
37.
ValenzuelaJMSmithLBStaffordJM, et al. Shared decision-making among caregivers and health care providers of youth with type 1 diabetes. J Clin Psychol Med Settings. 2014;21(3):234-243. doi:10.1007/s10880-014-9400-9
38.
LipmanTHMurphyKMKumanyikaSKRatcliffeSJJawadAFGinsburgKR.Racial differences in parents’ perceptions of factors important for children to live well with diabetes. Diabetes Educ. 2012;38(1):58-66. doi:10.1177/0145721711427454
39.
NaranjoDSchwartzDDelamaterAM.Diabetes in ethnic minority youth: disparate burden and intervention approaches. Curr Diabetes Rev. 2015;11:251-260. doi:10.2174/1573399811666150421115846
40.
WildDvon MaltzahnRBrohanEChristensenTClausonPGonder-FrederickL.A critical review of the literature on fear of hypoglycemia in diabetes: implications for diabetes management and patient education. Patient Educ Couns. 2007;68(1):10-15. doi:10.1016/j.pec.2007.05.003
41.
FreckletonESharpeLMullanB.The relationship between maternal fear of hypoglycaemia and adherence in children with type-1 diabetes. Int J Behav Med. 2014;21(5):804-810. doi:10.1007/s12529-013-9360-8
42.
SueDWSueD.Counseling the Culturally Different: Theory & Practice. 2nd ed.Wiley & Sons; 1990.
43.
ResnicowKBaranowskiTAhluwaliaJSBraithwaiteRL.Cultural sensitivity in public health: defined and demystified. Ethn Dis. 1999;9:10-21.
44.
WalkerAFHoodKKGurkaMJ, et al. Barriers to technology use and endocrinology care for underserved communities with type 1 diabetes. Diabetes Care. 2021;44(7):1480-1490. doi:10.2337/dc20-2753
45.
ChalewSDelamaterAMWashingtonS, et al. Can innovative technologies overcome HbA1c disparity for African-American youth with type 1 diabetes?J Diabetes Sci Technol. 2021;15(5):1069-1075. doi:10.1177/19322968211021386
46.
HoweCJMoroneJHawkesCPLipmanTH.Racial disparities in technology use in children with type 1 diabetes: a qualitative content analysis of parents’ perspectives. Sci Diabetes Self Manag Care. 2023;49(1):55-64. doi:10.1177/26350106221145323
47.
BarnardKDWysockiTUllyV, et al. Closing the loop in adults, children and adolescents with suboptimally controlled type 1 diabetes under free living conditions: a psychosocial substudy. J Diabetes Sci Technol. 2017;11(6):1080-1088. doi:10.1177/1932296817702656
48.
PhillipMNimriRBergenstalRM, et al. Consensus recommendations for the use of automated insulin delivery technologies in clinical practice. Endocr Rev. 2023;44(2):254-280. doi:10.1210/endrev/bnac022
49.
ScalzoP.From the Association of Diabetes Care & Education Specialists: the role of the diabetes care and education specialist as a champion of technology integration. Sci Diabetes Self Manag Care. 2021;47(2):120-123. doi:10.1177/0145721721995478
50.
EllisDARhindJCarconeAI, et al. Optimizing recruitment of black adolescents into behavioral research: a multi-center study. J Pediatr Psychol. 2021;46(6):611-620. doi:10.1093/jpepsy/jsab008
